Literature DB >> 19384587

Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4.

M L Castellani1, P Conti, M Felaco, J Vecchiet, C Ciampoli, G Cerulli, P Boscolo, T C Theoharides.   

Abstract

Substance P (SP) is an important neuropeptide involved in neurogenic inflammation and most of its pathophysiological functions are mediated through binding to the neurokinin-1 receptor. SP exerts various proinflammatory actions on immune-cells, including macrophages. Several compounds such as cytokines have the capacity to activate and stimulate macrophages to produce arachidonic acid oxygenation and lipoxygenation products. Leukotriene B4 (LTB4) is one of the most important mediators of leukocyte activation in acute and chronic inflammatory reactions. LTB4 stimulates chemotaxis, lysosomal enzyme release, and cell aggregation. In this report, we studied the effect of SP on rat adherent granuloma macrophages (RAGMs). The chronic granuloma in rat was induced by dorsal injections of a potassium permanganate (KMnO4) saturated crystal solution (200 microl of a 1:40 dilution). After 7 days, all rats developed a subcutaneous granuloma in the injection site from which infiltrated macrophages were extracted, isolated, and cultured in vitro. We tested the hypothesis that SP stimulates the production of LTB4 in RAGMs and increases lipoxygenase expression. Here we show that the cell-free supernatant of RAGMs stimulated with SP (10 microM), resulted in statistically significant increases of LTB4 Preincubation of RAGMs with NDGA (nordihydroguaiaretic acid (10 microM), completely abolished the production of LTB(4) in the supernatants and lipoxygenase expression on RAGMs challenged with SP, or the cation ionophore A23187 (positive control). Similar effects were obtained when the cells were pretreated with dexamethasone (10 microM). Our results suggest that SP is able to stimulate the release of LTB4 and lipoxygenase expression in macrophages from chronic inflammatory granuloma and provide further evidence for a neuroinflammatory pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384587     DOI: 10.1007/s12640-009-9004-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  53 in total

Review 1.  On the role of prolyl oligopeptidase in health and disease.

Authors:  J A García-Horsman; P T Männistö; J I Venäläinen
Journal:  Neuropeptides       Date:  2006-12-29       Impact factor: 3.286

Review 2.  5-Lipoxygenase: enzyme expression and regulation of activity.

Authors:  D Steinhilber
Journal:  Pharm Acta Helv       Date:  1994-07

3.  Neurokinin A engages neurokinin-1 receptor to induce NF-kappaB-dependent gene expression in murine macrophages: implications of ERK1/2 and PI 3-kinase/Akt pathways.

Authors:  Jia Sun; Raina Devi Ramnath; Ramasamy Tamizhselvi; Madhav Bhatia
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

4.  Size effects of nanomaterials on lung inflammation and coagulatory disturbance.

Authors:  K Inoue; H Takano; M Ohnuki; R Yanagisawa; M Sakurai; A Shimada; K Mizushima; T Yoshikawa
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Jan-Mar       Impact factor: 3.219

5.  Long-lasting production of TGF-beta1 by alveolar macrophages exposed to low doses of asbestos without apoptosis.

Authors:  Y Nishimura; T Nishiike-Wada; Y Wada; Y Miura; T Otsuki; H Iguchi
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Oct-Dec       Impact factor: 3.219

6.  A cutaneous infection caused by Brevundimonas vesicularis: a case report.

Authors:  V Panasiti; V Devirgiliis; M Mancini; M Curzio; M Rossi; D Fioriti; V Pietropaolo; R Nicosia; C Gallinelli; F Chiarini; G Pecorini; S Calvieri
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Apr-Jun       Impact factor: 3.219

7.  Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

Authors:  Dwight L Evans; Kevin G Lynch; Tami Benton; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David Metzger; Steven D Douglas
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

8.  Dexamethasone treatment reduces sensory neuropeptides and nerve sprouting reactions in injured teeth.

Authors:  Dung Hong; Margaret R Byers; Robert J Oswald
Journal:  Pain       Date:  1993-11       Impact factor: 6.961

9.  Poly-L-lactic acid beta-tricalcium phosphate screws: a preliminary in vivo biocompatibility study.

Authors:  N Magarelli; M A Savastano; D Palmieri; R Zappacosta; G Lattanzio; V Salini; C A Orso; G Guglielmi; C Colosimo
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Jan-Mar       Impact factor: 3.219

10.  Pulmonary exposure to diesel exhaust particle components enhances circulatory chemokines during lung inflammation.

Authors:  T Arimoto; H Takano; K Inoue; R Yanagisawa; S Yoshino; K Yamaki; T Yoshikawa
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Jan-Mar       Impact factor: 3.219

View more
  3 in total

1.  A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicum.

Authors:  Miao Liu; Peng Chen; Berthold Büchele; Shengjian Dong; Dake Huang; Cuiping Ren; Yuxia Zhang; Xin Hou; Thomas Simmet; Jijia Shen
Journal:  Parasitol Res       Date:  2012-12-28       Impact factor: 2.289

2.  Role of water in cyclooxygenase catalysis and design of anti-inflammatory agents targeting two sites of the enzyme.

Authors:  Manpreet Kaur; Baljit Kaur; Jagroop Kaur; Anudeep Kaur; Rajbir Bhatti; Palwinder Singh
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

Review 3.  Immunomodulatory Role of Neuropeptides in the Cornea.

Authors:  Sudan Puri; Brendan M Kenyon; Pedram Hamrah
Journal:  Biomedicines       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.